Delivery Order SPE2DB22D3009-SPE2DB25FBF78
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,628.16 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract is performed out of the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Yonsa 125 mg tablets (120-count units) valued at $2,271.36 with a firm fixed price structure. The order is scheduled for completion by May 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yonsa 125 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of YONSA 125 mg tablets (120-count units). This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a non-set-aside procurement under open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,814.08 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract. The award was issued on September 2, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) under a firm fixed-price contract type. The award, valued at $6.8K, was made on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a ceiling value of $4,542.74. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is to be completed by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units). This contract, issued on March 18, 2025, with an ultimate completion date of April 8, 2025, operates under a firm fixed-price structure with no set-aside designation. The award represents a competitive procurement action, reflecting the vendor's established capability to meet federal pharmaceutical supply requirements....
- The Defense Logistics Agency awarded a delivery order valued at $45,427.20 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF78Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,256.32 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract. The award, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. This delivery order is executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle valued through December 2026 that enables supply of medications and medical commodities to military healthcare systems globally. AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and healthcare solutions provider within the federal medical procurement ecosystem, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability across therapeutic domains including specialty medications, brand-name and generic pharmaceuticals, and medical supplies. This particular delivery order for Yonsa—a medication used in cancer treatment—reflects the company's role as a critical vendor supporting military and veteran healthcare procurement requirements through competitively awarded, firm fixed-price transactions managed by the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.3k | 9/27/25 |